Euronext introduces stock options on Arseus

Back

Brussels - 16 December 2013 – Euronext N.V., a wholly owned subsidiary of IntercontinentalExchange Group, Inc. (NYSE: ICE), will introduce options on the shares of Arseus (option trading symbol: RCU). The options will be available as of 16 December 2013 on the derivatives market of Euronext Brussels.

Arseus is a multinational group of companies that provides products, services and concepts for professionals active in the healthcare sector in 30 countries in Europe, North America, South America, Asia and Australia. Arseus is active in the markets for pharmaceutical compounding for pharmacies, medical ICT solutions, and dental, medical and surgical products and concepts.

Ger van Jeveren, CEO van Arseus: "The listing of Arseus on Euronext Brussels and Amsterdam on October 5, 2007 was an important milestone for Arseus. Both the company and the stock price have shown strong growth since the listing. Arseus has developed rapidly into a leading company with a strong focus on innovative products and concepts with substantial added value. The listing of options on the shares of our company marks a further step in Arseus’ development. We believe that this may offer shareholders an alternative financial instrument on Euronext, enhance the liquidity of our share, and increase the visibility of Arseus in the financial markets.

Vincent Van Dessel, CEO and Chairman of Euronext Brussels: “We are pleased to announce the introduction of the Arseus options, providing investors with new investment opportunities. Arseus option class will benefit from the growing interest in Belgian options we’ve seen over the past year.

Leen Van Wambeke, Senior Business Development Manager Benelux at Euronext Brussels added: “The listing of this new option class brings the total number of listed Individual Equity Options in Brussels to 21. With the addition of the Arseus option class to our existing central order book contracts, we are offering our market participants a highly diversified set of liquid derivatives for their investment needs.

These American-style options will expire on the third Friday of the contract month and will have initial maturities of 1, 2, 3, 6, 9 and 12 months. Each option will represent 100 shares in RCU and will be cleared via LCH.Clearnet SA.

Euronext lists over 200 equity options (also known as individual stock options) on leading European companies via the Amsterdam, Brussels, London and Paris central order books.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 2,000 listed issuers and around €5.8 trillion in market capitalisation as of end June 2022, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2022, Euronext N.V. - All rights reserved.